The WHO says the pipeline for new antibiotics faces a "dual crisis" of scarcity and lack of innovation and that simpler, faster, and cheaper diagnostics are needed for low-resource settings.
The researchers note an increase in VE of 28 percentage points for a second dose in vaccine-naive children younger than 3 years but none when including children up to 8 years.
Uneven distribution of cases makes it difficult to call the situation a global rise, but ongoing transmission and several risk factors boost the potential for further spread, the WHO says.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"The pandemic clock is ticking. I would still say the most likely source is going to be a coronavirus. Is it five years? Ten years? I don’t know, but I can say with certainty: I believe it’s going to happen. It’s just a matter of time."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
